Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1971 Dec 4;105(11):1157–1161.

Laboratory screening. A critical survey. II.

C C Korvin, R H Pearce
PMCID: PMC1931409  PMID: 5150074

Full text

PDF
1157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bryan D. J., Wearne J. L., Viau A., Musser A. W., Schoonmaker F. W., Thiers R. E. Profile of admission chemical data by multichannel automation: an evaluative experiment. Clin Chem. 1966 Mar;12(3):137–143. [PubMed] [Google Scholar]
  2. Collen M. F., Feldman R., Siegelaub A. B., Crawford D. Dollar cost per positive test for automated multiphasic screening. N Engl J Med. 1970 Aug 27;283(9):459–463. doi: 10.1056/NEJM197008272830905. [DOI] [PubMed] [Google Scholar]
  3. Collen M. F., Kidd P. H., Feldman R., Cutler J. L. Cost analysis of a multiphasic screening program. N Engl J Med. 1969 May 8;280(19):1043–1045. doi: 10.1056/NEJM196905082801905. [DOI] [PubMed] [Google Scholar]
  4. Cotlove E., Harris E. K., Williams G. Z. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 3. Physiological and medical implications. Clin Chem. 1970 Dec;16(12):1028–1032. [PubMed] [Google Scholar]
  5. Davey P. W., Letts H. W., Anderson P. A. Experience with a hospital laboratory admission screen. Can Med Assoc J. 1970 Jul 18;103(2):140–146. [PMC free article] [PubMed] [Google Scholar]
  6. Donaldson R. J., Howell J. M. A multiple screening clinic. Br Med J. 1965 Oct 30;2(5469):1034–1036. doi: 10.1136/bmj.2.5469.1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harris E. K., Kanofsky P., Shakarji G., Cotlove E. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. II. Estimating biological components of variation. Clin Chem. 1970 Dec;16(12):1022–1027. [PubMed] [Google Scholar]
  8. Keating F. R., Jr The clinical problem of primary hyperparathyroidism. Med Clin North Am. 1970 Mar;54(2):511–529. [PubMed] [Google Scholar]
  9. Mikkelsen W. M., Robinson W. D. Physiologic and biochemical basis for the treatment of gout and hyperuricemia. Med Clin North Am. 1969 Nov;53(6):1331–1347. [PubMed] [Google Scholar]
  10. Murphy E. A., Abbey H. The normal range--a common misuse. J Chronic Dis. 1967 Feb;20(2):79–88. doi: 10.1016/0021-9681(67)90099-9. [DOI] [PubMed] [Google Scholar]
  11. Nadel E., Mantel N., Kaplan N., Altschuler H. Individuality in serum lactic dehydrogenase (LDH) activity in aged perons:significance for cancer diagnosis. Ann N Y Acad Sci. 1969 Sep 30;161(2):581–601. doi: 10.1111/j.1749-6632.1969.tb34092.x. [DOI] [PubMed] [Google Scholar]
  12. Rardin T. E. Laboratory profile screening in family practice. A five-year study. JAMA. 1970 Nov 16;214(7):1262–1268. [PubMed] [Google Scholar]
  13. Schoen I. Clinical chemistry. A retrospective look at routine screening. Calif Med. 1968 Jun;108(6):430–436. [PMC free article] [PubMed] [Google Scholar]
  14. Weatherburn M. W., Stewart B. J., Logan J. E., Walker C. B., Allen R. H. A survey of hemoglobin values in Canada. Can Med Assoc J. 1970 Mar 14;102(5):493–498. [PMC free article] [PubMed] [Google Scholar]
  15. Young D. M., Drake N., Weir R. J. The advent of chemical screening techniques. Can Med Assoc J. 1968 May 4;98(18):868–870. [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES